Study Reveals Inequities in Access to Transformative CAR T Cell Therapy
Patients being treated for B-cell non-Hodgkin’s Lymphoma (NHL) who are part of minority populations may not have equal access to cutting-edge CAR T cell therapies, according to a new analysis led by researchers from the Perelman School of Medicine and published in NEJM Evidence. CAR T cell therapy is a personalized form of cancer therapy …
Continue reading “Study Reveals Inequities in Access to Transformative CAR T Cell Therapy”